35052852|t|Puerarin Attenuates Obesity-Induced Inflammation and Dyslipidemia by Regulating Macrophages and TNF-Alpha in Obese Mice.
35052852|a|Obesity causes low-grade inflammation that results in dyslipidemia and insulin resistance. We evaluated the effect of puerarin on obesity and metabolic complications both in silico and in vivo and investigated the underlying immunological mechanisms. Twenty C57BL/6 mice were divided into four groups: normal chow, control (HFD), HFD + puerarin (PUE) 200 mg/kg, and HFD + atorvastatin (ATO) 10 mg/kg groups. We examined bodyweight, oral glucose tolerance test, serum insulin, oral fat tolerance test, serum lipids, and adipocyte size. We also analyzed the percentage of total, M1, and M2 adipose tissue macrophages (ATMs) and the expression of F4/80, tumor necrosis factor-alpha (TNF-alpha), C-C motif chemokine ligand 2 (CCL2), CCL4, CCL5, and C-X-C motif chemokine receptor 4. In silico, we identified the treatment-targeted genes of puerarin and simulated molecular docking with puerarin and TNF, M1, and M2 macrophages based on functionally enriched pathways. Puerarin did not significantly change bodyweight but significantly improved fat pad weight, adipocyte size, fat area in the liver, free fatty acids, triglycerides, total cholesterol, and HDL-cholesterol in vivo. In addition, puerarin significantly decreased the ATM population and TNF-alpha expression. Therefore, puerarin is a potential anti-obesity treatment based on its anti-inflammatory effects in adipose tissue.
35052852	20	27	Obesity	Disease	MESH:D009765
35052852	36	48	Inflammation	Disease	MESH:D007249
35052852	53	65	Dyslipidemia	Disease	MESH:D050171
35052852	96	105	TNF-Alpha	Gene	21926
35052852	115	119	Mice	Species	10090
35052852	121	128	Obesity	Disease	MESH:D009765
35052852	146	158	inflammation	Disease	MESH:D007249
35052852	175	187	dyslipidemia	Disease	MESH:D050171
35052852	192	210	insulin resistance	Disease	MESH:D007333
35052852	239	247	puerarin	Chemical	MESH:C033607
35052852	251	258	obesity	Disease	MESH:D009765
35052852	263	286	metabolic complications	Disease	MESH:D020739
35052852	379	386	C57BL/6	CellLine	CVCL:C0MU
35052852	387	391	mice	Species	10090
35052852	457	465	puerarin	Chemical	MESH:C033607
35052852	467	470	PUE	Chemical	MESH:C033607
35052852	493	505	atorvastatin	Chemical	MESH:D000069059
35052852	507	510	ATO	Chemical	MESH:D000069059
35052852	558	565	glucose	Chemical	MESH:D005947
35052852	628	634	lipids	Chemical	MESH:D008055
35052852	765	770	F4/80	Gene	13733
35052852	772	799	tumor necrosis factor-alpha	Gene	21926
35052852	801	810	TNF-alpha	Gene	21926
35052852	813	841	C-C motif chemokine ligand 2	Gene	20296
35052852	843	847	CCL2	Gene	20296
35052852	850	854	CCL4	Gene	20303
35052852	856	860	CCL5	Gene	20304
35052852	957	965	puerarin	Chemical	MESH:C033607
35052852	1003	1011	puerarin	Chemical	MESH:C033607
35052852	1016	1019	TNF	Gene	21926
35052852	1085	1093	Puerarin	Chemical	MESH:C033607
35052852	1216	1232	free fatty acids	Chemical	MESH:D005230
35052852	1234	1247	triglycerides	Chemical	MESH:D014280
35052852	1255	1266	cholesterol	Chemical	MESH:D002784
35052852	1310	1318	puerarin	Chemical	MESH:C033607
35052852	1347	1350	ATM	Gene	11920
35052852	1366	1375	TNF-alpha	Gene	21926
35052852	1399	1407	puerarin	Chemical	MESH:C033607
35052852	1428	1435	obesity	Disease	MESH:D009765
35052852	1464	1476	inflammatory	Disease	MESH:D007249
35052852	Positive_Correlation	MESH:C033607	MESH:D002784
35052852	Negative_Correlation	MESH:C033607	MESH:D020739
35052852	Negative_Correlation	MESH:C033607	21926
35052852	Positive_Correlation	MESH:C033607	MESH:D005230
35052852	Association	MESH:D050171	21926
35052852	Negative_Correlation	MESH:C033607	MESH:D007249
35052852	Negative_Correlation	MESH:C033607	11920
35052852	Negative_Correlation	MESH:C033607	MESH:D009765
35052852	Positive_Correlation	MESH:C033607	MESH:D014280

